The alteration of intracellular signaling on the smooth muscle cells contraction in cat esophagitis.
D000109:Acetylcholine / Q000494:pharmacology; D000208:Acute Disease; D000818:Animals; D001952:Bridged-Ring Compounds / Q000494:pharmacology; D002415:Cats; D004195:Disease Models, Animal; D004336:Drug Antagonism; D004941:Esophagitis / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D004943:Esophagogastric Junction / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D004963:Estrenes / Q000494:pharmacology; D018727:Muscarinic Antagonists / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology*; D009130:Muscle, Smooth / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D009636:Norbornanes; D043265:Phosphatidylinositol Diacylglycerol-Lyase / Q000037:antagonists & inhibitors; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D054801:Phosphoinositide Phospholipase C; D011433:Propranolol / Q000494:pharmacology; D011760:Pyrrolidinones / Q000494:pharmacology; D011976:Receptors, Muscarinic / Q000378:metabolism; D015398:Signal Transduction; D013859:Thiocarbamates; D013871:Thiones / Q000494:pharmacology
D001952:Bridged-Ring Compounds; D004963:Estrenes; D018727:Muscarinic Antagonists; D009636:Norbornanes; D010726:Phosphodiesterase Inhibitors; D011760:Pyrrolidinones; D011976:Receptors, Muscarinic; D013859:Thiocarbamates; D013871:Thiones; C060229:1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione; C046498:tricyclodecane-9-yl-xanthogenate; D011433:Propranolol; D054801:Phosphoinositide Phospholipase C; D043265:Phosphatidylinositol Diacylglycerol-Lyase; D000109:Acetylcholine